Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
Open Access
- 29 July 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (15), 4935-4943
- https://doi.org/10.1158/1078-0432.ccr-09-0226
Abstract
Purpose: Minimally invasive methods of predicting the risk of muscle-invasive urothelial bladder carcinoma may expedite appropriate therapy and reduce morbidity and cost.Keywords
Other Versions
This publication has 42 references indexed in Scilit:
- CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsProteomics – Clinical Applications, 2008
- Discovery and validation of urinary biomarkers for prostate cancerProteomics – Clinical Applications, 2008
- Urinary Proteomic Biomarkers in Coronary Artery DiseaseMolecular & Cellular Proteomics, 2008
- High‐resolution proteome/peptidome analysis of peptides and low‐molecular‐weight proteins in urineProteomics – Clinical Applications, 2007
- Progesterone receptor membrane component 1: An integrative reviewThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant MetastasesClinical Cancer Research, 2007
- Risk factors for adverse outcomes after transurethral resection of bladder tumorsCancer, 2006
- Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface‐enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Epidemiology of Bladder CancerEuropean Urology, 1999
- Multiple bladder biopsies under intravesical lignocaine anaesthesiaBritish Journal of Urology, 1994